Prescription for Profit: 2005 Pharmaceutical-Biotech Industry Forecast Reveals Over $13 billion for Capital/MRO Projects in 2005

---

Researched by Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas) The Pharmaceutical-Biotech industry wrapped up 2004 being attacked from all directions. Vaccine shortages, product failures, stem cell research, spiraling prescription costs; the list of challenges this sector faces seems to grow almost daily. Despite these heavy blows to corporate images and profits, the very nature of this non-cyclic industry continues to spur its growth. According to Industrialinfo.com’s just released 2005 North American Pharmaceutical-Biotech Forecast, the drug industry will kick-off over $13 billion worth of Capital/MRO projects in 2005.

The Great Lakes and Mid-Atlantic regions begin 2005 accounting for the largest portion of forecasted Capital/MRO spending, with over 81 projects valued at over $5 billion. The West Coast’s 36 projects valued at $1.21 billion put the region just ahead of the Southeast, which enters 2005 anticipating the start of a healthy $1.2 billion spread over 30 projects. The 2005 North American Pharmaceutical-Biotech Forecast follows project activity, reflecting changes on a quarterly basis.

Click on the image at right to view the 2005 North American Pharma-Biotech Spending by Market Region Chart.

Despite the roller coaster rise and fall of the economic scene, the fact remains that a successful drug the public either needs or desires will need the facilities to develop, test, produce, package and distribute it. Companies have become more cautious before green-lighting major capital investments in facilities and in some cases, have abandoned interstate expansion plans, choosing instead to expand existing facilities.

The 2005 North American Pharmaceutical-Biotech Forecast Offers a Wealth of Information in one easy-to-access format! Features include:

· Forecast Spending – 2005 Capital and MRO spending, 2005 Major Project Spending Analysis by Market Region, and 5-Year Spending Analysis by Year, Market Region and SIC, the Industry’s Top 20 Capital Investors and more.
· Market Trends – Coverage includes important trends in such areas as Business, Economic and Regulatory that drive capital spending. These informative overviews clearly illustrate what issues will impact the industry in 2005 and beyond.
· Quarterly Updates – Your information remains timely with the Annual and regionally categorized Capital and MRO Spending Projections automatically updated each quarter.
· Plant Trends – Quarterly updates of new plant start-ups and closures. Conveniently divided into Annual, Market Region and SIC categories.
· Top Lists – Annual top 20 Pharmaceutical Companies, Top 10 Biotech Companies, Top Therapy Classes and more!
· Annual Updates – Total number of Operational Plants in the U.S., Canada and Mexico. Historical Plant Trends featuring a 2004 analysis by Market Region and plant start-ups for the past decade.

Each order includes a complimentary copy of the "2005 North American Pharmaceutical-Biotech Wall Map" - a $125 value.

Over 100 new Pharmaceutical-Biotech facilities are scheduled to come on line in 2005. As tracked by Industrialinfo.com, these projects cover both manufacturing plants and R&D laboratories. Updated quarterly, the 2005 North American Pharmaceutical-Biotech Forecast tracks both plant openings and closures.

Click here to for immediate access to Industrialinfo.com’s 2005 North American Pharmaceutical-Biotech Forecast

Industrialinfo.com is the leading provider of global industrial market research. We specialize in helping companies develop information solutions to maximize their sales and marketing efforts.